Twitter | Search | |
Ramon Varcoe
Vascular Surgeon at Prince of Wales hospital, Sydney and Associate Professor of Vascular Surgery at University of New South Wales. These views are my own.
151
Tweets
158
Following
427
Followers
Tweets
Ramon Varcoe retweeted
CX Symposium May 26
live with ⁦⁩ + ⁦⁦⁩ on their respective meta analyses.
Reply Retweet Like
Ramon Varcoe May 25
I look forward to presenting in the session on Paclitaxel in patients with CLI at this year! Join us on 26th May at 16.00 BST by following this link . Hope to see you there!
Reply Retweet Like
Ramon Varcoe retweeted
Vascular Specialist Online May 15
Reply Retweet Like
Ramon Varcoe retweeted
CX Symposium May 15
Paclitaxel controversy to headline inaugural CX 2020 LIVE session - Complimentary registration:
Reply Retweet Like
Ramon Varcoe May 5
and I reply to the latest meta from Katsanos etal in CLI. A flawed study can be dangerous, causing a change in practice to withold effective therapeutic tools from care of our patients.
Reply Retweet Like
Ramon Varcoe May 2
Medtronic’s Endurant Stent Graft Evaluated in Real-World Experience Treating 180 Patients With AAA on
Reply Retweet Like
Ramon Varcoe retweeted
Vascular Disease Mgm Apr 29
Ramon Varcoe, MBBS, MS, PhD, talks about his recent publication of a large prospective study that evaluated long-term outcomes in 180 patients treated with the Endurant Stent Graft system over an 11-year period.
Reply Retweet Like
Ramon Varcoe Apr 29
New study uses data linkage methodology to investigate long term results with the endurant stent-graft system. Results may surprise you... Particularly the comparison between patients on- and off-IFU, using this contemporary device
Reply Retweet Like
Ramon Varcoe Mar 11
Recently presented at AVF2020 the 12-mo results of the clinical feasibility study for endovenous valve formation to treat deep vein reflux. 6.3 pt mean reduction in VCSS score at 1-yr follow up (n=10), and no occlusive DVT’s. Early but encouraging data!
Reply Retweet Like
Ramon Varcoe retweeted
Vascular Disease Mgm Feb 24
Varcoe: New Meta-Analysis Shows No Difference in Mortality w/ Paclitaxel-Coated vs Uncoated Devices in CLI
Reply Retweet Like
Ramon Varcoe retweeted
VERVE Symposium Nov 25
With just over 2 weeks to go it's time to check out the program for the 2019 VERVE Symposium!!! It's one not-to-be-missed
Reply Retweet Like
Ramon Varcoe retweeted
Brian DeRubertis Nov 22
Important time for patients suffering the threat of limb loss. Looking forward to the exciting work we have ahead of us in helping to evaluate this technology for our patients.
Reply Retweet Like
Ramon Varcoe Nov 14
Bioresorbable scaffold effectively treats below-the-knee lesions
Reply Retweet Like
Ramon Varcoe Nov 13
Ascertainment bias could explain paclitaxel mortality signal
Reply Retweet Like
Ramon Varcoe retweeted
TCTMD Nov 7
Two small but promising studies presented at hint that the future may be looking brighter for interventions. Read: Hope for Vascular Scaffolds in Peripheral Disease Below the Knee? by
Reply Retweet Like
Ramon Varcoe retweeted
Raghu Kolluri Nov 3
My co-moderator presents a fantastic talk on what severe peripheral artery disease and severe venous disease can learn from “each other”! Better clarity on ulcer management on VLU end. Better clarity on the PAD end in rest of the areas.
Reply Retweet Like
Ramon Varcoe retweeted
Atul Gupta, MD Sep 30
Nice analysis in latest : "The mortality rates for pts treated with Stellarex DCB vs uncoated PTA were indistinguishable over 3-yr followup"
Reply Retweet Like
Ramon Varcoe Aug 29
Endovascular Today - Meta-Analysis Evaluates Mortality After Paclitaxel-Coated Device Use in Dialysis Access
Reply Retweet Like
Ramon Varcoe retweeted
VERVE Symposium Aug 28
New meta-analysis of RCTs shows NO association between paclitaxel coated balloons and mortality when used in dialysis access
Reply Retweet Like
Ramon Varcoe retweeted
Peter@InRoadMedical Aug 19
This week has been so rewarding professionally and personally. The 4th edition of Endovascular Skills has gone to print and will be available Sept 5. This has truly been a labor of love. I have enjoyed reflecting on how much the field has evolved this past decade
Reply Retweet Like